All Publications
9 min read

Turkey–U.S. M&A Daily Digest: Platinum Equity–Nestlé Peranel JV, Berkshire–Taylor Morrison Close, Paramount–WBD Freeze | ULF New York

M&A & Corporate Transactions

Turkey–U.S. M&A Daily Digest: Platinum Equity–Nestlé Peranel JV, Berkshire–Taylor Morrison Close, Paramount–WBD Freeze

The most significant Turkey-linked development of the period is U.S.-based Platinum Equity's agreement to become a 50% partner in Nestlé's global water operations — a joint venture that reportedly includes Erikli Su in Turkey. In the U.S., Berkshire Hathaway completed its $8.5 billion acquisition of Taylor Morrison, while the Paramount–Warner Bros. Discovery mega-deal was frozen pending state antitrust litigation.

U
ULF New York
9 min read

Executive Summary

As of 15:00 TST, July 25, 2026 | Review period: July 24, 2026 15:00 – July 25, 2026 15:00

The most significant Turkey-linked development of the period is U.S.-based Platinum Equity's agreement to become a 50% partner in Nestlé's global water operations. The Peranel joint venture, with an enterprise value of approximately €4.9 billion, reportedly includes Nestlé's Turkish water operations — Erikli Su — within its scope.

In the U.S., Berkshire Hathaway completed its $8.5 billion acquisition of Taylor Morrison. By contrast, the Lisata Therapeutics–Kuva Labs transaction was terminated after the buyer failed to secure the required financing. The Paramount–Warner Bros. Discovery mega-deal was frozen pending resolution of state antitrust litigation or until June 1, 2027.

Turkey–U.S. Linked Transaction

1. Platinum Equity–Nestlé: Peranel Joint Venture and Erikli Su

PartiesU.S.-based Platinum Equity; Switzerland-based Nestlé
Turkey connectionErikli Su and Nestlé's local water operations in Turkey
SectorBottled water, premium beverages, and functional hydration
Enterprise valueApproximately €4.9 billion — $5.6 billion
Nestlé's expected cash proceedsApproximately €3 billion
Ownership structure50% Nestlé – 50% Platinum Equity
Expected closingFirst half of 2027

Nestlé and Platinum Equity have agreed to transform Nestlé's water and premium beverages division into an independent joint venture under the name Peranel. Peranel will manage more than 30 brands — including S.Pellegrino, Source Perrier, Acqua Panna, Nestlé Pure Life, and various local water brands — across approximately 120 countries. While the official announcement does not enumerate local brands individually, current Turkish press reports indicate that Erikli is included within the transaction scope.

Legal and commercial significance: This transaction is not limited to a straightforward 50% share sale. Nestlé's production facilities, employees, water sources, brands, distribution relationships, and information systems across different countries will be carved out into a newly established independent entity. Platinum Equity, as a co-controlling shareholder, will indirectly participate in the strategic management of water operations in Turkey.

Implementation assessment: For Turkey, the precise perimeter of the companies, brands, and assets within the transaction scope must first be established. If Turkish Competition Authority approval is required, the transaction will be reviewed as a joint venture and change of control. Key documentation issues will include:

  • Ownership and licensing structure of the Erikli brand
  • Permits and licenses relating to water sources and bottling facilities
  • Land, lease, and water source usage rights
  • Distributor and retail agreements
  • Employee transition to the new structure
  • Transitional services to be continued by Nestlé
  • Board veto rights, deadlock, and exit mechanisms

Existing or potential administrative risks related to water usage and environmental sustainability must also be addressed through specific indemnification provisions.

Completed U.S. Transaction

2. Berkshire Hathaway–Taylor Morrison

PartiesBerkshire Hathaway Inc.; Taylor Morrison Home Corporation
SectorResidential development, construction, mortgage, and rental housing
Equity valueApproximately $6.8 billion
Enterprise valueApproximately $8.5 billion
Consideration$72.50 per share in cash
StatusTransaction completed July 24, 2026

Berkshire Hathaway completed the all-cash acquisition of Taylor Morrison, one of the leading U.S. homebuilders. Taylor Morrison will be combined with Clayton Properties Group's 15 regional homebuilders within the Berkshire portfolio. The combined entity will have delivered approximately 23,000 homes based on 2025 data, operating across 21 states, 52 housing markets, and more than 700 communities. The companies announced that the combined operation will become the fourth-largest homebuilding platform in the United States.

Legal and commercial significance: The transaction integrates Berkshire's modular and site-built housing operations at national scale. Taylor Morrison's Esplanade, Yardly, and Taylor Morrison Home Funding businesses are included within the transaction scope, consolidating land development, homebuilding, rental housing, and mortgage services under a single economic structure.

Implementation assessment: Post-closing, the focus of legal work will shift to integration. Key areas include land bank ownership and zoning status, joint venture projects, municipal development agreements, infrastructure obligations, consumer warranty claims, and mortgage operation licenses. As Berkshire consolidates different regional brands onto a single platform, contractor licenses, local government permits, and purchase contracts must be preserved on a state-by-state basis.

New U.S. Insurance Transaction

3. Horace Mann–Medical Mutual of Ohio Operations

PartiesHorace Mann Educators Corporation; Medical Mutual of Ohio
SectorInsurance, employee benefits, and support services
Total net purchase priceApproximately $240 million
FinancingExisting capital surplus and revolving credit facility
Expected closingsESI: Q4 2026; RNIC and reinsurance transaction: Q1 2027

Horace Mann will acquire the membership interests of employee support services provider Employee Services LLC and all of the capital stock of Reserve National Insurance Company. It will also reinsure the group life and disability portfolio of MedMutual Life Insurance Company, while the relevant licensed insurance entity will remain within Medical Mutual. Rating agency AM Best made no changes to Horace Mann's and its subsidiaries' existing ratings following the announced transactions.

Legal and commercial significance: The transaction employs three distinct legal techniques simultaneously: acquisition of limited liability company interests, transfer of shares in a regulated insurance company, and economic transfer of an insurance portfolio through reinsurance. This structure allows Horace Mann to expand its employee benefits and group insurance operations while Medical Mutual retains certain licensed legal entities.

Implementation assessment: State insurance authority approvals, capital adequacy, technical reserves, reinsurance collateral, and policyholder protection will be the primary closing conditions. Given that the ESI and RNIC transactions close on different dates, transitional services, customer referrals, brand usage, and cost-sharing must be governed by separate agreements.

Failed Transaction and Financing Risk

4. Termination of Lisata Therapeutics–Kuva Labs Transaction

PartiesLisata Therapeutics Inc.; Kuva Labs Inc.; Kuva Acquisition Corp.
SectorBiotechnology and pharmaceutical development
Contemplated consideration$4.00 per share in cash plus contingent value rights of up to $3.00
StatusMerger agreement terminated July 24, 2026
Termination fee$2 million

Lisata terminated the merger agreement after Kuva Labs failed to validly tender the shares at the expiration of the offer period. Kuva reported that it was unable to secure sufficient resources to finance the acquisition. Under the agreement, Kuva is obligated to pay Lisata a $2 million termination fee; Lisata also reserved its other legal rights with respect to willful breach and expenses incurred in enforcing the agreement.

Legal and commercial significance: The case clearly illustrates the impact of the financing condition and the buyer's payment capacity on deal certainty. Even though the offer was accepted by shareholders, the inability to fund the acquisition price prevented closing.

Implementation assessment: From the seller's perspective, the mere existence of bank or investor commitment letters should not be considered sufficient. The availability of financing sources, funding conditions, sponsor guarantees, reverse termination fees, and specific performance rights must be evaluated together. Whether the $2 million termination fee here adequately covers Lisata's actual damages and the cost of seeking a new transaction will be at the center of any potential dispute.

Major Deal Process Update

5. Paramount Skydance–Warner Bros. Discovery

PartiesParamount Skydance; Warner Bros. Discovery
SectorFilm, television, cable broadcasting, and digital platforms
Announced merger valueApproximately $81 billion
Estimated value including debtApproximately $111 billion
New closing restrictionUntil court ruling or June 1, 2027

Paramount and Warner Bros. Discovery agreed not to close the transaction while an antitrust lawsuit brought by 12 U.S. states remains pending. The transaction will wait until five days after the court issues a ruling on the merits, or until June 1, 2027 at the latest. The parties and the states also cancelled the preliminary injunction hearing scheduled for August 3, accepting that the case will proceed to a substantive antitrust trial.

Despite the U.S. Department of Justice not objecting to the transaction, state attorneys general argue that competition will be reduced in the markets for theatrical film distribution, exhibition of major studio films, and licensing of basic cable channels. If the transaction does not close by September 30, Paramount is required to pay Warner shareholders an additional approximately $7 million per day.

Legal and commercial significance: The development demonstrates that a favorable outcome in federal merger review in the U.S. does not eliminate the risk of lawsuits brought by states. A delay that could extend to approximately one year may significantly alter the transaction economics and financing costs.

Implementation assessment: The parties' financing commitment periods, the long-stop date, ticking fees, reverse termination fees, and ordinary course operating restrictions applicable until closing must be renegotiated. During the extended waiting period, the parties must preserve their competitive independence, manage employee and customer attrition, and limit sensitive information sharing through clean-team mechanisms.

Other Notable Process: Amex GBT–Long Lake

In Long Lake's take-private of American Express Global Business Travel at $9.50 per share in cash for approximately $6.3 billion in total, certain shareholders filed suit in New York alleging deficiencies in the proxy disclosures. While Amex GBT denied the allegations, it voluntarily published supplemental disclosures on July 24 to avoid transaction delays. Shareholders will vote on the transaction at a special meeting on August 3, 2026.

Practice note: In U.S. public company transactions, management projections, investment bank valuation analyses, conflicts of interest, and the chronology of transaction negotiations are the primary sources of litigation risk. Making supplemental disclosures does not mean the transaction price or contract terms have changed, but is intended to reduce the risk of a preliminary injunction blocking the vote.

Turkish Domestic Transactions

During the review period, no significant new Turkish corporate merger, demerger, or change of control was identified in KAP and Turkish Competition Authority sources following the MİA Teknoloji–Lider Sistem Teknolojileri merger reported in the previous digest. The most recent official announcement regarding the MİA transaction was published on July 24, 2026 at 08:07, which falls outside this reporting period.

This digest is prepared by ULF New York for informational purposes only and does not constitute legal advice. For advice on specific transactions, please contact our attorneys.

Explore Topics

#M&A#Platinum-Equity#Nestlé#Erikli#Berkshire-Hathaway#Taylor-Morrison#Paramount#Warner-Bros-Discovery#Horace-Mann#Lisata-Therapeutics#joint-venture#antitrust#deal-termination#media#housing#insurance#Turkey-US
U

Written by

ULF New York

ULF New York legal team — New York-based attorneys advising Turkish companies and investors on U.S. market entry, corporate law, real estate, and international trade.

Share this article

X
ULF New York Bülteni

ABD Hukuk Rehberlerini
Doğrudan Alın

E-posta adresiniz yalnızca ULF New York hukuki içerikleri için kullanılır. İstediğiniz zaman aboneliğinizi iptal edebilirsiniz.

Related analysis and guides

Further Reading

M&A & Corporate Transactions3 min read

Solstice / Element Solutions $14.5B Acquisition: Transaction Update — July 12, 2026

A follow-up update on the Solstice Advanced Materials / Element Solutions definitive agreement. The cash-and-stock transaction — $10.00 per share plus 0.500 Solstice shares, representing approximately 15% premium to Element Solutions' July 2 closing price — remains on track for a first-half 2027 close. A KAP scan as of July 12, 2026 shows no new Turkish public company disclosures in the merger, demerger, or tender offer categories.

Read article
M&A & Corporate Transactions6 min read

Solstice Advanced Materials to Acquire Element Solutions for Approximately $14.5 Billion

Solstice Advanced Materials has announced a definitive agreement to acquire Element Solutions Inc. for approximately $14.5 billion in enterprise value — a mixed cash-and-stock transaction offering Element shareholders $10.00 per share in cash plus 0.5 shares of Solstice. The deal creates a specialty chemicals and advanced materials platform with approximately $29 billion in combined enterprise value and $6.8 billion in annual sales, targeting AI infrastructure, semiconductor manufacturing, and data center thermal management markets.

Read article
M&A & Corporate Transactions5 min read

Sky (Comcast) to Acquire ITV's Broadcasting and Streaming Unit for Up to £1.6 Billion

Sky, a subsidiary of U.S.-based Comcast Corporation, has announced a definitive agreement to acquire ITV's media and entertainment division — including ITV channels and the ITVX streaming platform — for up to £1.6 billion (approximately $2.1 billion). ITV Studios will remain independent. The transaction reflects the accelerating consolidation of traditional broadcasters facing structural pressure from global streaming platforms.

Read article
M&A & Corporate Transactions9 min read

Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for Approximately $10 Billion

Vertex Pharmaceuticals Inc. has announced a definitive agreement to acquire Crinetics Pharmaceuticals Inc. for approximately $10 billion in an all-cash transaction — $85 per share, representing a premium of approximately 102% to Crinetics' closing price. The deal brings Vertex a commercial-stage rare endocrine disease franchise anchored by FDA-approved Palsonify and a late-stage pipeline asset in congenital adrenal hyperplasia, with combined peak annual sales potential projected above $5 billion.

Read article

Published

Saturday, July 25, 2026

Back to Publications